Literature DB >> 26547369

Portal and splanchnic hemodynamics after partial splenic embolization in cirrhotic patients with hypersplenism.

Ahmed Z Helaly1, Mohamed S Al-Warraky2, Gasser I El-Azab3, Mohamed A S Kohla3, Elsayed E Abdelaal3.   

Abstract

To assess the acute effects of partial splenic embolization (PSE) on portal and splanchnic hemodynamics in patients with cirrhosis. Ninety-five patients with hypersplenism were included in the study. Duplex examinations were performed before and 3 and 7 days after PSE. Portal and splanchnic hemodynamics including vessel cross-sectional area (CSA), mean flow velocities (cm/s), blood flows (mL/min), Doppler indices as portal congestion index (CI), liver vascular index, hepatic artery and superior mesenteric artery (SMA) pulsatility and resistive indices (PI and RI), were performed before and after PSE. In our study, 69 of 95 patients were males (72.6%) and 26 females (27.3%). Chronic hepatitis C virus infection was the main cause of cirrhosis (81.1%). PSE failed technically in six patients (6.3%). After PSE, both CSA and CI significantly decreased (p < 0.05 and <0.01). The portal vein velocity significantly increased (p < 0.01). The portal flow volume (892.4 ± 151 mL/min) did not show significant changes. The hepatic artery RI and PI showed a steady increase that became significant 7 days post-PSE (p < 0.05). The RI and PI of SMA increased significantly after 7 days of PSE (p < 0.05). PSE has an immediate portal decompression effect in patients with portal hypertension without reduction in portal flow. This effect on portal pressure should be investigated in future studies as a potential tool for management of acute variceal bleeding when other medical procedures fail.
© 2015 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Portal; hemodynamics; hypersplenism; splenic embolization

Mesh:

Year:  2015        PMID: 26547369     DOI: 10.1111/apm.12470

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  6 in total

1.  A case of percutaneous transhepatic stomal varices embolization and partial splenic artery embolization for rectal cancer after CAPOX/BEV chemotherapy: the summary of the stomal varices related to oxaliplatin administration.

Authors:  Shoichiro Mizukami; Tatsuya Shonaka; Chikayoshi Tani; Kazuki Ihara; Tomohiro Takeda; Mizuho Ohara; Kimiharu Hasegawa; Mishie Tanino; Koji Sawada; Yasuo Sumi
Journal:  Clin J Gastroenterol       Date:  2022-10-20

Review 2.  Progress in Endoscopic and Interventional Treatment of Esophagogastric Variceal Bleeding.

Authors:  Bin Liu; Gang Li
Journal:  Dis Markers       Date:  2022-05-06       Impact factor: 3.464

3.  Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial.

Authors:  Yanjing Gao; Xin Sun; Anzhong Zhang; Tao Zhou; Minghui Wang; Yong Chen; Ting Zhou; Xiaoning Chen; Aiyuan Xiu; Zhi Peng; Baoquan Cheng; Xiaofeng Liu
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

4.  Computed tomography portography of patients with cirrhosis with normal body mass index: Comparison between low-tube-voltage CT with low contrast agent dose and conventional CT.

Authors:  Sulan Liu; Huaqiang Sheng; Hao Shi; Wei Li; Jingli Fan; Jingzhen He; Hongjun Sun
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

5.  Observation of immediate and mid-term effects of partial spleen embolization in reducing hepatic venous pressure gradient.

Authors:  Yiming Zhao; Liangliang Guo; Qiyang Huang; Rugang Zhang; Xuyang Sun; Li Zhao; Chao Li; Yan Nie; Gang Sun; Jiangtao Liu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

6.  Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification.

Authors:  Tsuyoshi Ishikawa; Ryo Sasaki; Tatsuro Nishimura; Takashi Matsuda; Takuya Iwamoto; Issei Saeki; Isao Hidaka; Taro Takami; Isao Sakaida
Journal:  Intern Med       Date:  2020-12-07       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.